A new Supreme Court case U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine puts the expansion of mifepristone at risk, leading to less access to abortion and reproductive care. The FDA has added and changed restrictions and accessibility of Mifepristone over the past few years. Click the link below to read the full article and learn about the decisions made for the abortion pill.
This article was written by Wendy Parmet, affiliated faculty in WGSS. Wendy is also a co-PI on the Reproductive Justice Research Collaborative (RJRC) grant.
